Singapore markets open in 6 hours 21 minutes

Coherus BioSciences, Inc. (CHRS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.3400-0.2600 (-7.22%)
As of 02:38PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
No. of analysts7767
Avg. Estimate-0.29-0.05-1.590.22
Low estimate-0.67-0.35-2.06-0.46
High estimate0.030.25-0.80.8
Year ago EPS-0.96-0.6-3.02-1.59
Revenue estimateCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
No. of analysts8899
Avg. Estimate83.56M112.63M288.91M523.04M
Low estimate75M101.34M275.99M392.05M
High estimate96M132M303.65M674M
Year ago sales56.91M45.35M211.04M288.91M
Sales growth (year/est)46.80%148.30%36.90%81.00%
Earnings history29/09/202230/12/202230/03/202329/06/2023
Est. EPS-0.57-0.84-0.57-0.48
Actual EPS-0.96-0.6-0.75-0.38
Difference-0.390.24-0.180.1
Surprise %-68.40%28.60%-31.60%20.80%
EPS trendCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
Current estimate-0.29-0.05-1.590.22
7 days ago-0.29-0.05-1.590.22
30 days ago-0.29-0.05-1.590.22
60 days ago-0.36-0.1-1.740.2
90 days ago-0.30-1.650.64
EPS revisionsCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesCHRSIndustrySector(s)S&P 500
Current qtr.69.80%N/AN/AN/A
Next qtr.91.70%N/AN/AN/A
Current year47.40%N/AN/AN/A
Next year113.80%N/AN/AN/A
Next 5 years (per annum)-25.10%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A